E.V. Baranova

ORCID: 0000-0003-3211-7134
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Enzyme Structure and Function
  • Heat shock proteins research
  • Genetic Associations and Epidemiology
  • Pharmacogenetics and Drug Metabolism
  • Lipoproteins and Cardiovascular Health
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Cardiovascular Function and Risk Factors
  • Endoplasmic Reticulum Stress and Disease
  • Agriculture and Biological Studies
  • Protein Structure and Dynamics
  • Atrial Fibrillation Management and Outcomes
  • Pharmaceutical Economics and Policy
  • Glycosylation and Glycoproteins Research
  • Carbohydrate Chemistry and Synthesis
  • Redox biology and oxidative stress
  • Blood Coagulation and Thrombosis Mechanisms
  • Pharmaceutical studies and practices
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography
  • Invertebrate Immune Response Mechanisms
  • Agricultural Productivity and Crop Improvement
  • RNA modifications and cancer
  • Bacteriophages and microbial interactions
  • Aquaculture disease management and microbiota
  • Health Systems, Economic Evaluations, Quality of Life

Vrije Universiteit Brussel
2012-2023

VIB-VUB Center for Structural Biology
2012-2023

Vlaams Instituut voor Biotechnologie
2023

Utrecht University
2015-2020

University Medical Center Utrecht
2019-2020

University of Glasgow
2019

KU Leuven
2009-2014

Russian Academy of Sciences
2003

Recent genome-wide association studies identified single nucleotide polymorphisms (SNPs) on the chromosome 9p21.3 conferring risk for CAD (coronary artery disease) in individuals of Caucasian ancestry. We performed a genetic study to investigate effect 12 candidate SNPs within locus Saudi population Eastern Province Arabia. A total 250 patients who had experienced an myocardial infarction (MI) and 252 age-matched healthy controls were genotyped using TaqMan assay. Controls with evidenced...

10.3390/ijms17030395 article EN International Journal of Molecular Sciences 2016-03-17

The aim of the present study was to describe occurrence and determinants angiotensin-converting enzyme (ACE) inhibitor (ACEI) intolerance angioedema (AE) among patients initiating ACEI therapy in a real-world primary care population.Two nested case-control studies were conducted cohort 276 977 aged ≥45 years ACEIs from 2007 2014 UK Clinical Practice Research Datalink (CPRD). Cases AE occurring for first time during (n = 416) matched with AE-free controls 4335) on duration treatment....

10.1111/bcp.13090 article EN British Journal of Clinical Pharmacology 2016-08-15
Yi‐Juan Hu Amand F. Schmidt Frank Dudbridge Michael V. Holmes James M. Brophy and 95 more Vinicius Tragante Ziyi Li Peizhou Liao Arshed A. Quyyumi Raymond O. McCubrey Benjamin D. Horne Aroon D. Hingorani Folkert W. Asselbergs Riyaz Patel Long Qi Axel Åkerblom Ale Algra Hooman Allayee Peter Almgren Jeffrey L. Anderson Maria Grazia Andreassi Chiara Viviani Anselmi Diego Ardissino Benoît J. Arsenault Christie M. Ballantyne E.V. Baranova Hassan Behloui Thomas O. Bergmeijer Connie R. Bezzina Eyþór Björnsson Simon C. Body Bram Boeckx Eric Boersma Eric Boerwinkle Peter Bogaty Peter S. Braund Lutz Philipp Breitling Hermann Brenner Carlo Briguori Jasper J. Brugts Ralph Burkhardt Vicky A. Cameron John F. Carlquist Clara Carpeggiani Kathryn Carruthers Gavino Casu Gianluigi Condorelli Sharon Cresci Nicolas Danchin Ulf dé Fairé John Deanfield Graciela Delgado Panos Deloukas Kenan Direk Robert N. Doughty Heinz Drexel Núbia E. Duarte Marie‐Pierre Dubé Line Dufresne James C. Engert Niclas Eriksson Natalie Fitzpatrick Luisa Foco Ian Ford Keith A.A. Fox Bruna Gigante Crystel M. Gijsberts Domenico Girelli Yan Gong Daníel F. Guðbjartsson Emil Hagström Jaana Hartiala Stanley L. Hazen Claes Held Anna Helgadóttir Harry Hemingway Mahyar Heydarpour Imo E. Hoefer Kees Hovingh Jaroslav A. Hubáček Stefan James Julie A. Johnson J. Wouter Jukema Marcin Kaczor Karol Kamiński Jiří Kettner Marek Kiliszek Marcus E. Kleber Olaf H. Klungel Daniel Kofink Mika Kohonen Salma Kotti Pekka Kuukasjärvi Bo Lagerqvist Diether Lambrechts Chim C. Lang Jari Laurikka Karin Leander Vei‐Vei Lee Terho Lehtimäki

Background— Studies of recurrent or subsequent disease events may be susceptible to bias caused by selection subjects who both experience and survive the primary indexing event. Currently, magnitude any bias, particularly for time-to-event analysis in genetic association studies, is unknown. Methods Results— We used empirically inspired simulation studies explore impact on marginal hazard ratio risk among those with established coronary heart disease. The extent was determined magnitudes...

10.1161/circgenetics.116.001616 article EN Circulation Cardiovascular Genetics 2017-10-01

Abstract Angioedema in the mouth or upper airways is a feared adverse reaction to angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) treatment, which used for hypertension, heart failure diabetes complications. This candidate gene genome-wide association study aimed identify genetic variants predisposing angioedema induced by these drugs. The discovery cohort consisted of 173 cases 4890 controls recruited Sweden. In analysis, ETV6, BDKRB2, MME , PRKCQ were...

10.1038/s41397-020-0165-2 article EN cc-by The Pharmacogenomics Journal 2020-02-21

Angioedema occurring in the head and neck region is a rare sometimes life‐threatening adverse reaction to angiotensin‐converting enzyme inhibitors (ACEIs) angiotensin receptor blockers (ARBs). Few studies have investigated association of common variants with this extreme reaction, but none explored combined influence yet. Adjudicated cases ACEI‐induced angioedema (ACEI‐AE) or ARB‐induced (ARB‐AE) controls were recruited at five different centers. Sequencing 1,066 samples (408 ACEI‐AE,...

10.1002/cpt.1927 article EN cc-by-nc Clinical Pharmacology & Therapeutics 2020-06-04

Small heat-shock proteins (sHsps) are ubiquitous molecular chaperones. sHsps function as homooligomers or heterooligomers that prone to subunit exchange and structural plasticity. Here, a procedure for obtaining diffraction-quality crystals of the α-crystallin domain human Hsp27 is presented. Initially, limited proteolysis was used delineate corresponding stable fragment (residues 90–171). This could be crystallized, but examination using X-rays indicated partial disorder. The...

10.1107/s1744309109044571 article EN Acta Crystallographica Section F Structural Biology and Crystallization Communications 2009-11-27

To assess the required characteristics (cost, sensitivity and specificity) of a pharmacogenomic test for being cost-effective prevention angiotensin-converting enzyme inhibitors induced angioedema. Furthermore, we assessed influence only testing high-risk populations.A decision tree was used.With willingness-to-pay threshold €20,000 €80,000 per quality adjusted life year, 100% sensitive specific may have maximum cost €1.30 €1.95, respectively. When genotyping populations, price would be...

10.2217/pgs-2017-0063 article EN Pharmacogenomics 2017-07-26

Mycoredoxins (Mrxs) are a group of small dithiol oxidoreductases that share conserved CXXC active site sequence motif resembling glutaredoxins. They commonly found in saprophytic microorganisms, including Actinobacteria such as Mycobacterium tuberculosis. Among the known mycoredoxins, Corynebacterium glutamicum (Cg) Mrx1, featuring CVQC site, functions mycothiol-dependent monothiol oxidoreductase. On other hand, Mrx2, also NrdH-redoxin and containing same motif, exhibits oxidoreductase...

10.1016/j.rbc.2023.100014 article EN cc-by-nc-nd Redox Biochemistry and Chemistry 2023-09-19
Coming Soon ...